Physiologic Response Evaluation of Human Foetal Osteoblast Cells within Engineered 3D-Printed Polylactic Acid Scaffolds

Simple Summary Large bone defect treatments have always represented an important challenge in clinical practice and created a large demand for more efficacious regenerative approaches. The bone tissue engineering approach offered a new alternative to conventional bone grafts, addressing all clinical needs. Among the most used biomaterials for bone tissue engineering, polylactic acid scaffolds have been considered the most promising ones due to their good biocompatibility, non-toxic biodegradability and bioresorbability. In this work, we evaluated the physiological response of human foetal osteoblast cells, in terms of cell proliferation and osteogenic differentiation, within oxygen plasma treated 3D-printed polylactic acid scaffolds, obtained by fused deposition modelling. The obtained data suggested that 3D-printed polylactic acid scaffolds represent promising biomaterials for medical implantable devices in the orthopaedic field and have the potential to increase patients' quality of life. Large bone defect treatments have always been one of the important challenges in clinical practice and created a huge demand for more efficacious regenerative approaches. The bone tissue engineering (BTE) approach offered a new alternative to conventional bone grafts, addressing all clinical needs. Over the past years, BTE research is focused on the study and realisation of new biomaterials, including 3D-printed supports to improve mechanical, structural and biological properties. Among these, polylactic acid (PLA) scaffolds have been considered the most promising biomaterials due to their good biocompatibility, non-toxic biodegradability and bioresorbability. In this work, we evaluated the physiological response of human foetal osteoblast cells (hFOB), in terms of cell proliferation and osteogenic differentiation, within oxygen plasma treated 3D-printed PLA scaffolds, obtained by fused deposition modelling (FDM). A mechanical simulation to predict their behaviour to traction, flexural or torque solicitations was performed. We found that: 1. hFOB cells adhere and grow on scaffold surfaces; 2. hFOB grown on oxygen plasma treated PLA scaffolds (PLA_PT) show an improvement of cell adhesion and proliferation, compared to not-plasma treated scaffolds (PLA_NT); 3. Over time, hFOB penetrate along strands, differentiate, and form a fibrous matrix, tissue-like; 4. 3D-printed PLA scaffolds have good mechanical behaviour in each analysed configuration. These findings suggest that 3D-printed PLA scaffolds could represent promising biomaterials for medical implantable devices in the orthopaedic field.

Automated summary

Large bone defect treatments have always been a challenge in clinical practice and there is a high demand for more effective regenerative approaches. The bone tissue engineering approach offers a new alternative to conventional bone grafts, addressing all clinical needs. Polylactic acid (PLA) scaffolds, as one of the most promising biomaterials for bone tissue engineering, have good biocompatibility, non-toxic biodegradability and bioresorbability. This study evaluated the physiological response of human foetal osteoblast cells within oxygen plasma treated 3D-printed PLA scaffolds and found that they could potentially be used as biomaterials for medical implantable devices in the orthopaedic field.